• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

综合生物信息学分析确定与肺鳞状细胞癌预后和免疫浸润相关的关键转录组。

Integrated bioinformatics analyses identifying key transcriptomes correlated with prognosis and immune infiltrations in lung squamous cell carcinoma.

作者信息

Alghamdi Rana A, Al-Zahrani Maryam H

机构信息

Department of Chemistry, Science and Arts College, King Abdulaziz University, Rabigh, Saudi Arabia.

Biochemistry Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.

出版信息

Saudi J Biol Sci. 2023 Apr;30(4):103596. doi: 10.1016/j.sjbs.2023.103596. Epub 2023 Feb 11.

DOI:10.1016/j.sjbs.2023.103596
PMID:36879671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9985037/
Abstract

BACKGROUND

Lung Squamous Cell Carcinoma (LUSC) is a major subtype of lung malignancies and is associated with the cause of cancer-mediated mortality worldwide. However, identification of transcriptomic signatures associated with survival-prognosis and immunity of tumor remains lacking.

METHOD

The GSE2088, GSE6044, GSE19188, GSE21933, GSE33479, GSE33532, and GSE74706 were integrated for identifying differentially expressed genes (DEGs) with combined effect sizes. Also, the TCGA LUSC cohort was used for further analysis. A series of bioinformatics methods were utilized for conducting the whole study.

RESULTS

The 831 genes (such as and ) were found upregulated and the 731 genes (such as and ) were downregulated in the LUSC. The functional enrichment analysis identifies the upregulated KEGG pathways, including cell cycle, DNA replication, base excision repair, proteasome, mismatch repair, and cellular senescence. Also, the key hub genes (such as and ) were identified along with the eight gene modules that were significantly related to the protein-protein interaction (PPI) The clinical analyses identified that the overexpression group of and are substantially associated with a poor survival prognosis and the downregulated group of showed a similar trend. Moreover, our investigation demonstrated that the survival-associated genes were correlated with the stromal and immune scores in LUSC, indicating that the survival-associated genes regulate tumor immunity. The survival-associated genes were genetically altered in 27% of LUSC patients and showed excellent diagnostic efficiency. Finally, the consistent expression level of and were found in the TCGA LUSC cohort.

CONCLUSIONS

The identification of key transcriptomic signatures can be elucidated by the crucial mechanism of LUSC carcinogenesis.

摘要

背景

肺鳞状细胞癌(LUSC)是肺恶性肿瘤的主要亚型,与全球癌症介导的死亡原因相关。然而,仍缺乏与肿瘤生存预后和免疫相关的转录组特征的鉴定。

方法

整合GSE2088、GSE6044、GSE19188、GSE21933、GSE33479、GSE33532和GSE74706以鉴定具有联合效应大小的差异表达基因(DEG)。此外,使用TCGA LUSC队列进行进一步分析。采用一系列生物信息学方法进行整个研究。

结果

在LUSC中发现831个基因(如 和 )上调,731个基因(如 和 )下调。功能富集分析确定了上调的KEGG通路,包括细胞周期、DNA复制、碱基切除修复、蛋白酶体、错配修复和细胞衰老。此外,还鉴定了关键枢纽基因(如 和 )以及与蛋白质-蛋白质相互作用(PPI)显著相关的八个基因模块。临床分析表明, 和 的过表达组与较差的生存预后显著相关,而下调组也呈现类似趋势。此外,我们的研究表明,生存相关基因与LUSC中的基质和免疫评分相关,表明生存相关基因调节肿瘤免疫。生存相关基因在27%的LUSC患者中发生基因改变,并显示出优异的诊断效率。最后,在TCGA LUSC队列中发现了 和 的一致表达水平。

结论

关键转录组特征的鉴定可以通过LUSC致癌的关键机制来阐明。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8242/9985037/99a85c84edf2/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8242/9985037/2a09ebb97bdf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8242/9985037/4c3135ca2ddd/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8242/9985037/e0d89984c20d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8242/9985037/467aeeb70eed/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8242/9985037/a094edd4905a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8242/9985037/683941bc7d08/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8242/9985037/e2174d301296/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8242/9985037/5e29e6acbeee/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8242/9985037/99a85c84edf2/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8242/9985037/2a09ebb97bdf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8242/9985037/4c3135ca2ddd/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8242/9985037/e0d89984c20d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8242/9985037/467aeeb70eed/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8242/9985037/a094edd4905a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8242/9985037/683941bc7d08/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8242/9985037/e2174d301296/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8242/9985037/5e29e6acbeee/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8242/9985037/99a85c84edf2/gr9.jpg

相似文献

1
Integrated bioinformatics analyses identifying key transcriptomes correlated with prognosis and immune infiltrations in lung squamous cell carcinoma.综合生物信息学分析确定与肺鳞状细胞癌预后和免疫浸润相关的关键转录组。
Saudi J Biol Sci. 2023 Apr;30(4):103596. doi: 10.1016/j.sjbs.2023.103596. Epub 2023 Feb 11.
2
Identification of key genes associated with progression and prognosis for lung squamous cell carcinoma.肺鳞状细胞癌进展和预后相关关键基因的鉴定
PeerJ. 2020 May 6;8:e9086. doi: 10.7717/peerj.9086. eCollection 2020.
3
Identification of key genes and evaluation of clinical outcomes in lung squamous cell carcinoma using integrated bioinformatics analysis.利用综合生物信息学分析鉴定肺鳞状细胞癌中的关键基因并评估临床结局
Oncol Lett. 2019 Dec;18(6):5859-5870. doi: 10.3892/ol.2019.10933. Epub 2019 Sep 30.
4
High Expression Levels of CDK1 and CDC20 in Patients With Lung Squamous Cell Carcinoma are Associated With Worse Prognosis.肺鳞状细胞癌患者中CDK1和CDC20的高表达水平与较差的预后相关。
Front Mol Biosci. 2021 Jul 7;8:653805. doi: 10.3389/fmolb.2021.653805. eCollection 2021.
5
Four hub genes regulate tumor infiltration by immune cells, antitumor immunity in the tumor microenvironment, and survival outcomes in lung squamous cell carcinoma patients.四个枢纽基因调节肿瘤浸润免疫细胞、肿瘤微环境中的抗肿瘤免疫以及肺鳞癌患者的生存结局。
Aging (Albany NY). 2021 Jan 10;13(3):3819-3842. doi: 10.18632/aging.202351.
6
Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma.脂质代谢相关基因 PTGIS 和 HRASLS 对肺鳞癌表型、预后和肿瘤免疫的影响。
Oxid Med Cell Longev. 2023 Jan 17;2023:6811625. doi: 10.1155/2023/6811625. eCollection 2023.
7
Screening and identification of key biomarkers in lung squamous cell carcinoma by bioinformatics analysis.通过生物信息学分析筛选和鉴定肺鳞状细胞癌中的关键生物标志物
Oncol Lett. 2019 Nov;18(5):5185-5196. doi: 10.3892/ol.2019.10873. Epub 2019 Sep 16.
8
Prediction of immune subtypes and overall survival in lung squamous cell carcinoma.肺鳞状细胞癌免疫亚型及总生存期的预测
Curr Med Res Opin. 2023 Feb;39(2):289-298. doi: 10.1080/03007995.2022.2129231. Epub 2022 Dec 14.
9
Meta-analysis identifying epithelial-derived transcriptomes predicts poor clinical outcome and immune infiltrations in ovarian cancer.荟萃分析鉴定上皮衍生转录组预测卵巢癌不良临床结局和免疫浸润。
Math Biosci Eng. 2021 Jul 30;18(5):6527-6551. doi: 10.3934/mbe.2021324.
10
Low Expression of ADCY4 Predicts Worse Survival of Lung Squamous Cell Carcinoma Based on Integrated Analysis and Immunohistochemical Verification.基于综合分析和免疫组织化学验证,ADCY4低表达预示肺鳞状细胞癌患者预后更差
Front Oncol. 2021 Jun 10;11:637733. doi: 10.3389/fonc.2021.637733. eCollection 2021.

引用本文的文献

1
Connexin43 Promotes the Invasion and Metastasis of Lung Squamous Cell Carcinoma via GJIC-Dependent Ca/ERK Signaling Activation.连接蛋白43通过依赖缝隙连接细胞间通讯的钙/细胞外信号调节激酶信号激活促进肺鳞状细胞癌的侵袭和转移。
Cancer Sci. 2025 Aug;116(8):2086-2100. doi: 10.1111/cas.70076. Epub 2025 May 31.
2
New Amidino-Substituted Benzimidazole Derivatives as Human Dipeptidyl Peptidase III Inhibitors: Synthesis, In Vitro Evaluation, QSAR, and Molecular Docking Studies.新型脒基取代苯并咪唑衍生物作为人二肽基肽酶III抑制剂:合成、体外评价、定量构效关系及分子对接研究
Int J Mol Sci. 2025 Apr 20;26(8):3899. doi: 10.3390/ijms26083899.
3

本文引用的文献

1
CDH3 is associated with poor prognosis by promoting the malignancy and chemoresistance in oral squamous cell carcinoma.CDH3 通过促进口腔鳞状细胞癌的恶性转化和化疗耐药性与不良预后相关。
Asian J Surg. 2022 Dec;45(12):2651-2658. doi: 10.1016/j.asjsur.2022.01.075. Epub 2022 Mar 17.
2
Screening of hub genes associated with prognosis in non-small cell lung cancer by integrated bioinformatics analysis.通过综合生物信息学分析筛选与非小细胞肺癌预后相关的枢纽基因
Transl Cancer Res. 2020 Nov;9(11):7149-7164. doi: 10.21037/tcr-20-1073.
3
Cancer statistics, 2022.
Mechanism of the GALNT family proteins in regulating tumorigenesis and development of lung cancer (Review).
GALNT家族蛋白在调控肺癌发生发展中的机制(综述)
Mol Clin Oncol. 2025 Mar 5;22(4):37. doi: 10.3892/mco.2025.2832. eCollection 2025 Apr.
4
KEAP1-NRF2 Interaction in Cancer: Competitive Interactors and Their Role in Carcinogenesis.癌症中的KEAP1-NRF2相互作用:竞争性相互作用分子及其在致癌作用中的作用
Cancers (Basel). 2025 Jan 28;17(3):447. doi: 10.3390/cancers17030447.
5
Aspartoacylase promotes the process of tumour development and is associated with immune infiltrates in gastric cancer.天冬氨酸酶可促进肿瘤的发展过程,并与胃癌中的免疫浸润有关。
BMC Cancer. 2023 Jun 30;23(1):604. doi: 10.1186/s12885-023-11088-7.
癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
4
Identification of key tumor stroma-associated transcriptional signatures correlated with survival prognosis and tumor progression in breast cancer.鉴定与乳腺癌生存预后和肿瘤进展相关的关键肿瘤基质相关转录特征。
Breast Cancer. 2022 May;29(3):541-561. doi: 10.1007/s12282-022-01332-6. Epub 2022 Jan 12.
5
Mutation Is Associated With Tumor Mutation Burden and Promotes Antitumor Immunity in Lung Squamous Cell Carcinoma.突变与肿瘤突变负荷相关,并促进肺鳞状细胞癌的抗肿瘤免疫。
Front Cell Dev Biol. 2021 Oct 21;9:761758. doi: 10.3389/fcell.2021.761758. eCollection 2021.
6
Identification of prognostic markers by weighted gene co-expression network analysis in non-small cell lung cancer.基于加权基因共表达网络分析鉴定非小细胞肺癌的预后标志物。
Bioengineered. 2021 Dec;12(1):4924-4935. doi: 10.1080/21655979.2021.1960764.
7
JunD, not c-Jun, is the AP-1 transcription factor required for Ras-induced lung cancer.JunD,而非 c-Jun,是 Ras 诱导的肺癌中所需的 AP-1 转录因子。
JCI Insight. 2021 Jul 8;6(13):e124985. doi: 10.1172/jci.insight.124985.
8
GALNT2/14 overexpression correlate with prognosis and methylation: potential therapeutic targets for lung adenocarcinoma.GALNT2/14 过表达与预后和甲基化相关:肺腺癌的潜在治疗靶点。
Gene. 2021 Jul 20;790:145689. doi: 10.1016/j.gene.2021.145689. Epub 2021 May 5.
9
EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.EZH2 抑制剂可逆转原发性 EGFR 野生型肺癌细胞对吉非替尼的耐药性。
BMC Cancer. 2020 Dec 4;20(1):1189. doi: 10.1186/s12885-020-07667-7.
10
Desmoglein 3 and Keratin 14 for Distinguishing Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.桥粒芯糖蛋白3和角蛋白14用于鉴别肺腺癌和肺鳞状细胞癌。
Onco Targets Ther. 2020 Oct 29;13:11111-11124. doi: 10.2147/OTT.S270398. eCollection 2020.